Growth Metrics

Boston Scientific (BSX) Current Deferred Tax Assets (2016 - 2019)

Boston Scientific's Current Deferred Tax Assets history spans 11 years, with the latest figure at $195.0 million for Q4 2019.

  • On a quarterly basis, Current Deferred Tax Assets rose 124.14% to $195.0 million in Q4 2019 year-over-year; TTM through Dec 2019 was $195.0 million, a 124.14% increase, with the full-year FY2019 number at $195.0 million, up 124.14% from a year prior.
  • Current Deferred Tax Assets hit $195.0 million in Q4 2019 for Boston Scientific, up from $189.0 million in the prior quarter.
  • Over the last five years, Current Deferred Tax Assets for BSX hit a ceiling of $496.0 million in Q4 2015 and a floor of $43.0 million in Q3 2018.
  • Historically, Current Deferred Tax Assets has averaged $153.0 million across 5 years, with a median of $81.0 million in 2016.
  • Biggest five-year swings in Current Deferred Tax Assets: tumbled 84.88% in 2016 and later soared 339.53% in 2019.
  • Tracing BSX's Current Deferred Tax Assets over 5 years: stood at $496.0 million in 2015, then tumbled by 84.88% to $75.0 million in 2016, then decreased by 12.0% to $66.0 million in 2017, then surged by 31.82% to $87.0 million in 2018, then soared by 124.14% to $195.0 million in 2019.
  • Business Quant data shows Current Deferred Tax Assets for BSX at $195.0 million in Q4 2019, $189.0 million in Q3 2019, and $175.0 million in Q2 2019.